Search

Pages

1. • Dissertation

   • 

   Gènes codant des antigènes de rejet tumoral

   Van den Eynde, Benoît[UCL] (1994)
2. • Speech

   • 

   Challenges and opportunities in preclinical development of new immuno-oncological therapies

   Van den Eynde, Benoît[UCL] (2019) Oncodesign Symposium — Paris, France
3. • Speech

   • 

   Role of proteasome subtypes in the processing of tumor antigens and the degradation of oxidized proteins

   Van den Eynde, Benoît[UCL] (2019) 10th EMBO workshop on Antigen Processing and Presentation (APP 2019) — Paris, France
4. • Speech

   • 

   The dark side of immunology: peptide splicing by the proteasome and the role of IDO1 in immune regulation

   Van den Eynde, Benoît[UCL] (2019) Université Libre de Bruxelles - Séminaire — Bruxelles
5. • Speech

   • 

   Antigen processing and tumoral immunosuppression in the modern era of immuno-oncology

   Van den Eynde, Benoît[UCL] (2019) Seminar at Fred Hutch – Integrated Research Center Immunotherapy — Seattle, USA
6. • Speech

   • 

   Cancer vaccines based on viral vectors encoding MAGE-type antigens

   Van den Eynde, Benoît[UCL] (2019) Cancer Immunotherapy Immunomonitoring (CITIM 2019) — Tbilisi, Georgia
7. • Speech

   • 

   Invited Lecture: Restoring immune control of cancer

   Van den Eynde, Benoît[UCL] (2014) Symposium in honor of Anne-Marie Schmitt-Verhulst — Marseille (France)
8. • Speech

   • 

   Antigens recognized by T lymphocytes on human tumors

   Boon, Thierry[UCL] Van den Eynde, Benoît[UCL] van der Bruggen, Pierre[UCL] (1997) 12th International Histocompatibility Workshop & Conference — Paris, France
9. • Speech

   • 

   Invited lecture: Tumor antigens recognized by T-cells: molecular definition, intracellular processing, and clinical testing as vaccine targets

   Van den Eynde, Benoît[UCL] (2005) Annual Meeting of the American Association for Cancer Research (AACR) — Anaheim, USA
10. • BookChapter

    • 

    Identification of genes encoding T cell defined tum- antigens

    Van Pel, Aline[UCL] De Plaen, Etienne[UCL] Lurquin, Christophe[UCL] Van den Eynde, Benoît[UCL] Lethe, Bernard[UCL] Hainaut, Philippe[UCL] Lemoine, Carine[UCL] Boon, Thierry[UCL] (1989) Immune System and Cancer — [ISBN : 9780850668537]
11. • Speech

    • 

    Invited lecture: Expression of IDO in human mature dendritic cells in vivo

    Van den Eynde, Benoît[UCL] Théate, Ivan[UCL] Moulin, Pierre[UCL] Nizet, Yannick[UCL] Renauld, Jean-Christophe[UCL] Larrieu, Pierre[UCL] Hervé, Caroline[UCL] Pilotte, Luc[UCL] (2009) 2nd International IDO Meeting — Bonn, Germany
12. • Speech

    • 

    Invited lecture: Peptide splicing by the proteasome: a new mechanism to produce antigenic peptides presented by MHC class I molecules

    Van den Eynde, Benoît[UCL] Vigneron, Nathalie[UCL] Warren, Edus H Stroobant, Vincent[UCL] Chapiro, Jacques[UCL] Gavin, Marc A[UCL] Riddell, Stanley R Boon, Thierry[UCL] (2004) 8th International Symposium on Dendritic Cells — Brugge, Belgium
13. • Speech

    • 

    Invited lecture: A novel tumor immune escape mechanism based on tryptophan degradation by indoleamine 2,3 dioxygenase

    Van den Eynde, Benoît[UCL] (2003) Keystone Symposium "Cell Biology of the Immune Response" — Keystone, CO, USA
14. • Speech

    • 

    Invited lecture: Processing of tumor antigens and preclinical models for cancer immunotherapy

    Van den Eynde, Benoît[UCL] (2007) Immunology Review Club – Leiden Institute for Immunology - Leiden University — Leiden, The Netherlands
15. • Speech

    • 

    IDO in the tumor microenvironment and targeting it as a treatment

    Van den Eynde, Benoît[UCL] (2016) 2nd Human Cancer Immunology Course for Oncologists and Scientists — Brussels, Belgium
16. • Speech

    • 

    Opportunities and Challenges in the Use of Animal Models for Cancer Target Validation and Drug Development

    Van den Eynde, Benoît[UCL] (2015) AACR Annual meeting 2015 — Philadelphia, USA
17. • Speech

    • 

    Apoptosis of tumor-infiltrating lymphocytes as a druggable immune checkpoint

    Van den Eynde, Benoît[UCL] (2018) Crown Bio Symposium — Antwerpen, Belgium
18. • Speech

    • 

    Invited lecture: Tumor antigens and T lymphocytes

    Van den Eynde, Benoît[UCL] (1999) 6th Study Day of Surgical Oncology — Haasrode, Belgium
19. • Speech

    • 

    Microarray analysis of differential gene expression in B and CD4 T cells of SLE versus control patients

    Lauwerys, Bernard[UCL] Louahed, Jamila[UCL] Van den Eynde, Benoît[UCL] Houssiau, Frédéric[UCL] (2005) Annual European Congress of Rheumatology — Vienna (Austria)
20. • Speech

    • 

    Invited lecture: Genes coding for tumor rejection antigens

    Van den Eynde, Benoît[UCL] (1993) 8th Maimonides Conference on Cancer Research — Ein-Gedi, Israël
21. • BookChapter

    • 

    Tumour antigens recognized by cytolytic T lymphocytes: perspectives for specific immunotherapy of bladder cancer and other genitourinary tumours

    Marchand, Marie[UCL] Chatzopoulos, C. Brasseur, Francis[UCL] Guéguen, M. Patard, J.-J. François, P. Van Cangh, Paul[UCL] Van den Eynde, Benoît[UCL] (1996) European Urology Update Series — [ISBN : 978-9-0797-5470-0]
22. • Speech

    • 

    Invited lecture: Tumor antigens and mechanisms of tumoral immune resistance

    Van den Eynde, Benoît[UCL] (2009) 5th MUGEN Annual & Review Meeting — Athens, Greece
23. • Speech

    • 

    Invited Lecture: Progresses and challenges in cancer immunotherapy

    Van den Eynde, Benoît[UCL] (2014) Stamcelinstituut conference series — Leuven (Belgium)
24. • Speech

    • 

    Invited lecture: Recognition of tumor antigens

    Van den Eynde, Benoît[UCL] (2000) John Humphrey Course, European Federation of Immunological Societies — Sinaia, Romania
25. • BookChapter

    • 

    T-cell defined tumor antigens: perspectives for cancer vaccine development

    Van den Eynde, Benoît[UCL] (1999) Gann Monograph on Cancer Research, "Recent advances of human tumor immunology and immunotherapy" — [ISBN : 3-8055-6980-7]

Pages